Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

May 11, 2023 3:21 (London Time)

Amgen

Youtube Subscribe

...

Sector: Biotechnology
Ticker: AMGN
Sentiment: -0.3468
MarketCap: 126,085,046,386.0
High: 235.0 Low: 231.35

Open: 234.89 Close: 234.11 Change: -0.78

12 lessons that an AI found about Amgen Company Inc Stock after reading internet.

Are looking for the most relevant information about Amgen? Investor spend a lot of time searching for information to make investment decisions in Amgen. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, target, TScan, potential, investor, announce, Inc, and the most common words in the summary are: amgen, stock, inc, news, market, price, amgn, . One of the sentences in the summary was: Entera Bio, a former partner of Amgen, announced that both were ending a research …

Concept Map

...

Semantic Network

...

Stock Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's products include Enbrel, Prolia, Xgeva, Otezla, Aranesp, and Repatha..

Today's Summary

Amgen will use TScans target discovery platform to identify potential targets for Crohns disease. Entera Bio, a former partner of Amgen, announced that both were ending a research collaboration.

Today's News

Amgen will use TScans target discovery platform to identify potential targets for Crohns disease. Entera Bio, a former partner of Amgen, announced that both were ending a research collaboration that was first announced in 2018. Amgen Inc. is reviewing the complaint and has previously said that the allegations are without merit and overstated by billions of dollars. The complaint alleges that Amgens stock share price fell by 6.5% on August 4, 2021, and 4.3% on April 28, 2022, because the company waited until those dates to share the potential tax liability. Pomerantz LLP is investigating claims on behalf of investors of Amgen Inc. (NASDAQ: AMGN) Such investors are advised to contact Ro... Amgen (NASDAQ:AMGN) will present at the 2023 Bank of America Merrill Lynch Global Healthcare Conference at 11:00 a.m. May 3, 2023. Pomerantz LLP is investigating claims on behalf of investors of Amgen Inc. Such investors are advised to contact Rob... Kessler Topaz Meltzer & Check, LLP reminds Amgen inc. (amgn) shareholders of securities fraud class action lawsuit. Kessler Topz Meltzer and Check, LLC reminds investors that a securities class action. lawsuit has been filed in the United States District Court for the Southern District of New York. Third-quarter sales of Amgens new KRAS inhibitor Lumakras likely to have been higher than $77 million recorded in the second quarter. Amgen has a partnership with AstraZeneca AZN for Tezspire. Amgen and TScan Therapeutics announce collaboration to identify novel targets in crohns disease. Amgen will evaluate a variety of modalities to create therapeutics based on targets discovered by TScan. TScan to receive $30 million up front with potential development and commercial payments of $500 million. Pomerantz LLP is investigating claims on behalf of investors of Amgen Inc. (NASDAQ: AMGN) Amgen : 234.11 (-0.14%) Biotech ETFs Pop on M&A Resurgence Zacks. Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. Amgen and TScan Therapeutics announce collaboration to identify novel targets in Crohns disease. Amgen will evaluate a variety of modalities to create therapeutics based on targets discovered by TScan and will retain all global development and commercial rights. Amgen and TScan Therapeutics announce collaboration to identify novel targets in crohns disease. Amgen will evaluate a variety of modalities to create therapeutics based on targets discovered by TScan. TScan to Receive $30 million Upfront With Potential Development and Commercial Milestone Payments of Over $500 million. The Gross Law Firm Notifies Shareholders of Amgen Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 12, 2023 - (NASDAQ: AMGN) Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. Amgen has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

Stock Profile

"Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California."

Keywords

This document will help you to evaluate Amgen without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, target, TScan, potential, investor, announce, Inc, and the most common words in the summary are: amgen, stock, inc, news, market, price, amgn, . One of the sentences in the summary was: Entera Bio, a former partner of Amgen, announced that both were ending a research collaboration.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #amgen #stock #inc #news #market #price #amgn.

Read more →

Related Results

...
March 14, 2024 14:17 (London Time)

Amgen

Amgen reported fourth-quarter 2023 adjusted earnings of $4.71 per share, which beat the Zacks Consensus Estimate. Japan and Asia Pacific are the fas…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.991
MarketCap: 147,935,053,432.0
High: 276.95 Low: 272.3

Open: 276.84 Close: 273.17 Change: -3.67

Read more →
...
March 11, 2024 12:09 (London Time)

Amgen

Amgen announces 2024 second quarter dividend for second quarter of 2024. Board of Directors declared $2.25 per share dividend. Amgen Ohio will bring…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9418
MarketCap: 146,707,799,148.0
High: 276.56 Low: 272.01

Open: 272.81 Close: 273.75 Change: 0.94

Read more →
...
February 28, 2024 1:59 (London Time)

Amgen

Amgen has opened a new biomanufacturing plant in Central Ohio, US. Amgen is hosting an inaugural 18-month manufacturing apprenticeship at the site.
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9617
MarketCap: 153,471,095,679.0
High: 281.22 Low: 277.21

Open: 279.1 Close: 278.49 Change: -0.61

Read more →
...
February 20, 2024 23:38 (London Time)

Amgen

Amgen Inc. stock underperforms t Tuesday when compared to competitors - marketwatch.com.com. Amgen continues its sponsorship of the Irish Open follo…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9794
MarketCap: 152,066,988,158.0
High: 285.28 Low: 280.55

Open: 283.85 Close: 283.51 Change: -0.34

Read more →
...
February 17, 2024 3:11 (London Time)

Amgen

Goldman Sachs continues to hold a Buy rating for Amgen. Wall Street analysts forecast AMGN stock price to rise over the next 12 months. Amgen expect…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9423
MarketCap: 152,066,988,158.0
High: 287.71 Low: 283.27

Open: 287.71 Close: 283.7 Change: -4.01

Read more →
...
February 04, 2024 2:54 (London Time)

Amgen

Amgen announces webcast of 2023 fourth quarter and full year financial results. Q1 earnings are confirmed for Thursday, April 25, 2024. Amgen has in…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.8777
MarketCap: 173,049,815,030.0
High: 325.77 Low: 320.75

Open: 323.64 Close: 323.19 Change: -0.45

Read more →
...
February 02, 2024 19:14 (London Time)

Amgen

Amgen expected to beat expectations when it reports fourth-quarter and full-year 2023 results on Feb 6, after market close. U.S. Supreme Court will …
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.0516
MarketCap: 173,756,250,026.0
High: 325.77 Low: 320.75

Open: 323.64 Close: 323.11 Change: -0.53

Read more →
...
January 28, 2024 1:13 (London Time)

Amgen

Amgen Inc. stock outperforms competitors on strong trading day. Wells Fargo analyst Mohit Bansal maintained a Buy rating on Amgen yesterday and set …
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9774
MarketCap: 166,852,453,477.0
High: 312.02 Low: 309.86

Open: 310.57 Close: 311.77 Change: 1.2

Read more →
...
January 20, 2024 12:04 (London Time)

Amgen

Amgen shares of Amgen Inc. reachead $307.81 at the closing of the latest trading day, reflecting a +1.09% change compared to its last close. Amgen r…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9859
MarketCap: 164,722,444,930.0
High: 309.09 Low: 301.11

Open: 304.73 Close: 307.81 Change: 3.08

Read more →
...
January 14, 2024 15:40 (London Time)

Amgen

Amgen reachead $303.10 at the closing of the latest trading day. Amgen has a preclinical pipeline of “a half dozen or so” obesity candidates that ar…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.8399
MarketCap: 164,037,417,055.0
High: 306.95 Low: 303.4

Open: 305.24 Close: 306.51 Change: 1.27

Read more →
...
January 09, 2024 16:50 (London Time)

Amgen

Amgen CEO Robert Bradway spoke at the 42nd annual J.P. conference on Monday. Amgen opt-in to the collaboration with Generate:Biomedicines. Amgen has…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9001
MarketCap: 166,365,441,473.0
High: 309.96 Low: 305.94

Open: 308.02 Close: 307.61 Change: -0.41

Read more →
...
December 24, 2023 14:28 (London Time)

Amgen

Amgen Inc. stock outperforms competitors on strong trading day - marketwatch.com.
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9545
MarketCap: 152,076,188,152.0
High: 285.68 Low: 280.0

Open: 280.0 Close: 284.16 Change: 4.16

Read more →
...
December 21, 2023 11:15 (London Time)

Amgen

Amgen Inc. is largely controlled by institutional shareholders who own 78% of the company. Jay Bradner succeeds David Reese as Executive VP of Resea…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9422
MarketCap: 147,270,289,469.0
High: 278.8 Low: 275.01

Open: 277.83 Close: 275.18 Change: -2.65

Read more →
...
December 16, 2023 4:31 (London Time)

Amgen

Amgen recorded $6.5 billion in product sales from July through September, a 5% increase from the same three-month period in 2022. Amgen has received…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9933
MarketCap: 147,880,392,420.0
High: 279.27 Low: 273.33

Open: 276.27 Close: 275.45 Change: -0.82

Read more →
...
December 10, 2023 3:06 (London Time)

Amgen

Amgen v. Janssen v. Amgen argued full scope enablement is a novel requirement or one that Amgen has impacted. U.S. Supreme Court on Friday agreed to…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9869
MarketCap: 144,027,110,626.0
High: 271.97 Low: 268.82

Open: 271.17 Close: 269.12 Change: -2.05

Read more →
...
December 04, 2023 8:27 (London Time)

Amgen

Amgen Inc. announced a $27.8 billion buyout of Horizon Therapeutics last month. Amgen is laying off 300 people, predominantly in R&D and associated …
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9802
MarketCap: 145,830,660,577.0
High: 272.59 Low: 267.62

Open: 269.96 Close: 272.45 Change: 2.49

Read more →
...
December 01, 2023 4:59 (London Time)

Amgen

Amgen Inc. stock AMGN, +0.62% rose 2.9% in premarket trade Tuesday, after the biotech blew past earnings estimates for the third quarter and again r…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9709
MarketCap: 144,305,403,200.0
High: 270.56 Low: 267.34

Open: 267.71 Close: 269.64 Change: 1.93

Read more →
...
November 24, 2023 3:47 (London Time)

Amgen

Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and the Nasdaq-100 index. Amgen has on average historically risen by…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.945
MarketCap: 141,602,754,163.0
High: 266.47 Low: 262.26

Open: 264.79 Close: 264.59 Change: -0.2

Read more →
...
November 20, 2023 7:55 (London Time)

Amgen

Amgen Inc. shares rose 2.9% in premarket trade Tuesday, after the biotech blew past earnings estimates for the third quarter. Federal Trade Commissi…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9643
MarketCap: 142,030,896,585.0
High: 269.41 Low: 264.6

Open: 269.41 Close: 265.39 Change: -4.02

Read more →
...
November 04, 2023 21:15 (London Time)

Amgen

Amgen shares currently sit at $269.86.
Sector: Biotechnology
Ticker: AMGN
Sentiment: -0.8689
MarketCap: 142,673,110,217.0
High: 270.55 Low: 265.5

Open: 268.52 Close: 269.86 Change: 1.34

Read more →
...
October 30, 2023 23:19 (London Time)

Amgen

Amgen to lay off 350 Horizon employees after closing $27.8 billion deal. Amgen has been on a cost-cutting spree this year.
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.3335
MarketCap: 139,914,101,914.0
High: 266.35 Low: 262.5

Open: 265.0 Close: 263.19 Change: -1.81

Read more →
...
October 20, 2023 7:38 (London Time)

Amgen

Amgen closed at $283.58 in the latest trading session, marking a.3% move from the prior day. Amgen has an ESP ESP+ of +165%.
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.994
MarketCap: 150,093,271,388.0
High: 283.21 Low: 278.1

Open: 282.09 Close: 280.6 Change: -1.49

Read more →
...
October 08, 2023 19:57 (London Time)

Amgen

Amgen agreed to buy Horizon Theraputics for about a year. FDA voted against Amgen request for full approval of G12C KRAS inhibitor. FTC Agreement Cl…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9908
MarketCap: 143,086,065,917.0
High: 268.59 Low: 262.23

Open: 263.15 Close: 267.47 Change: 4.32

Read more →
...
October 04, 2023 15:07 (London Time)

Amgen

Amgen Inc. per Employee $1.045M P/E Ratio 17.63 EPS $14.63 Yield 3.26% Dividend $2.13 Ex-Dividend date Aug 17, 2023. Intuit stock (NASDAQ NDAQ : INT…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9756
MarketCap: 139,614,557,252.0
High: 263.19 Low: 260.91

Open: 262.1 Close: 261.46 Change: -0.64

Read more →
...
September 21, 2023 14:50 (London Time)

Amgen

Federal Trade Commission said the deal would enable Amgen to exploit its size to block competition for two expensive Horizon drugs. FTC and six stat…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9859
MarketCap: 145,204,274,594.0
High: 272.48 Low: 267.7

Open: 272.07 Close: 269.86 Change: -2.21

Read more →
...
September 11, 2023 5:40 (London Time)

Amgen

Amgen closed at $259.43, marking a +1.98% move from the previous day. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Averag…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.8221
MarketCap: 138,769,413,386.0
High: 260.34 Low: 254.97

Open: 255.75 Close: 259.43 Change: 3.68

Read more →
...
September 06, 2023 7:45 (London Time)

Amgen

FTC filed lawsuit in May seeking to block Amgen takeover of Horizon Therapeutics over concerns it would allow Amgen to leverage its drug portfolio t…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9771
MarketCap: 137,314,482,174.0
High: 257.39 Low: 253.92

Open: 256.71 Close: 254.01 Change: -2.7

Read more →
...
September 05, 2023 9:16 (London Time)

Amgen

FTC settles with Amgen over $27.8 billion takeover of Horizon Therapeutics. FTC had filed a lawsuit in May seeking to block the acquisition over con…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.6249
MarketCap: 137,314,482,174.0
High: 259.03 Low: 256.1

Open: 258.68 Close: 256.71 Change: -1.97

Read more →
...
August 28, 2023 15:29 (London Time)

Amgen

FTC Pauses Challenge to Amgens $27.8 billion deal for Horizon Therapeutics. FTC to consider whether the agency should settle the case. Amgen committ…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9761
MarketCap: 137,137,964,784.0
High: 258.12 Low: 255.8

Open: 256.96 Close: 256.04 Change: -0.92

Read more →
...
August 17, 2023 9:23 (London Time)

Amgen

Amgen (NASDAQ:AMGN) has shown growth in its earnings per share (EPS) Overall, Amgen appears to have a fairly valued stock. Amgen stock has seen a 17…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9966
MarketCap: 141,759,510,988.0
High: 268.24 Low: 264.58

Open: 266.33 Close: 265.02 Change: -1.31

Read more →
...
August 10, 2023 21:04 (London Time)

Amgen

Amgen declares $2.13 dividend. Amgen expects full-year earnings in the range of $17.80 to $18.80 per share.
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9614
MarketCap: 138,748,017,339.0
High: 264.78 Low: 260.46

Open: 261.54 Close: 262.06 Change: 0.52

Read more →
...
August 06, 2023 22:50 (London Time)

Amgen

62 analysts offering price forecasts for Amgen have a median target of 249.55, with a high estimate of 310.00 and a low estimate of 182.00. The proj…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.886
MarketCap: 124,027,888,999.0
High: 246.42 Low: 237.0

Open: 237.91 Close: 243.28 Change: 5.37

Read more →
...
July 22, 2023 18:29 (London Time)

Amgen

Amgen closed at $218.65, marking a -1.94% move from the previous day. Amgen shareholders have earned a 5.8% CAGR. Telos Capital Management Inc. acqu…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9893
MarketCap: 125,470,570,803.0
High: 236.38 Low: 232.78

Open: 233.77 Close: 234.82 Change: 1.05

Read more →
...
July 16, 2023 16:16 (London Time)

Amgen

Amgen (AMGN) shareholders have earned a 5.8% CAGR over the last five years. The projected fair value for Amgen is US$407 based on 2 Stom Pgo pricesi…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.836
MarketCap: 121,521,897,273.0
High: 228.66 Low: 225.96

Open: 227.84 Close: 227.43 Change: -0.41

Read more →
...
July 04, 2023 4:42 (London Time)

Amgen

Insiders at Amgen sold US$1.9m in stock, alluding to potential weakness. Amgen short percent of float has fallen 4.93% since its last report. Am Gen…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.4627
MarketCap: 118,171,669,529.0
High: 225.55 Low: 219.91

Open: 221.21 Close: 225.01 Change: 3.8

Read more →
...
June 24, 2023 10:22 (London Time)

Amgen

California, other states join FTC bid to block Amgen deal to buy Horizon Therapeutics. Washington Attorney General Bob Ferguson said his state had j…
Sector: Biotechnology
Ticker: AMGN
Sentiment: -0.128
MarketCap: 121,350,912,763.0
High: 230.54 Low: 226.41

Open: 229.87 Close: 227.11 Change: -2.76

Read more →
...
June 22, 2023 16:03 (London Time)

Amgen

Amgen closed at $229.66, marking a +0.53% move from the previous day. Amgen share price has underperformed the S&P500 Index by -17.98% over the past…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.978
MarketCap: 122,141,716,122.0
High: 229.41 Low: 226.76

Open: 227.31 Close: 229.18 Change: 1.87

Read more →
...
June 11, 2023 2:48 (London Time)

Amgen

Amgen Inc. (AMGN) closed at $218.82 in the latest trading session, marking a -0.88% move from the prior day. Amgen share price has underperformed th…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.7759
MarketCap: 116,889,285,703.0
High: 220.94 Low: 217.77

Open: 219.34 Close: 218.76 Change: -0.58

Read more →
...
June 05, 2023 20:07 (London Time)

Amgen

Federal Trade Commission sues to block Amgen acquisition of Horizon Therapeutics. FTC is attempting to stop the sale out of fears it will give the c…
Sector: Biotechnology
Ticker: AMGN
Sentiment: -0.7964
MarketCap: 126,085,046,386.0
High: 223.04 Low: 218.47

Open: 219.67 Close: 222.1 Change: 2.43

Read more →
...
May 27, 2023 2:34 (London Time)

Amgen

Federal Trade Commission sued to block Amgen Inc.s purchase of Horizon Therapeutics plc. FTC alleges the acquisition would allow Amgen to offer reba…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9679
MarketCap: 126,085,046,386.0
High: 218.48 Low: 214.48

Open: 215.96 Close: 216.93 Change: 0.97

Read more →
...
May 23, 2023 23:27 (London Time)

Amgen

U.S. Supreme Court rules against Amgen bid to revive cholesterol drug patents. Food and Drug Administration could approve Amgens biosimilar in secon…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.296
MarketCap: 126,085,046,386.0
High: 226.82 Low: 222.8

Open: 224.21 Close: 224.44 Change: 0.23

Read more →
...
May 23, 2023 2:05 (London Time)

Amgen

Federal Trade Commission said the deal would enable Amgen to exploit its size to block competition. FTC said deal would allow Amgen. to use rebates …
Sector: Biotechnology
Ticker: AMGN
Sentiment: -0.9824
MarketCap: 126,085,046,386.0
High: 226.82 Low: 222.82

Open: 224.85 Close: 223.99 Change: -0.86

Read more →
...
May 20, 2023 9:13 (London Time)

Amgen

Federal Trade Commission said the deal would enable Amgen to exploit its size to block competition. FTC said it believed Amgen could leverage its bi…
Sector: Biotechnology
Ticker: AMGN
Sentiment: -0.9926
MarketCap: 126,085,046,386.0
High: 225.88 Low: 222.78

Open: 224.44 Close: 223.42 Change: -1.02

Read more →
...
May 18, 2023 15:52 (London Time)

Amgen

FTC sues to block Amgen $27.8 billion deal to buy Horizon Therapeutics PLC (HZNP.O) Amgen struck a deal last year to. buy Horizon to strengthen its …
Sector: Biotechnology
Ticker: AMGN
Sentiment: -0.9951
MarketCap: 126,085,046,386.0
High: 224.75 Low: 222.52

Open: 224.75 Close: 222.61 Change: -2.14

Read more →
...
May 11, 2023 3:21 (London Time)

Amgen

Amgen will use TScans target discovery platform to identify potential targets for Crohns disease. Entera Bio, a former partner of Amgen, announced t…
Sector: Biotechnology
Ticker: AMGN
Sentiment: -0.3468
MarketCap: 126,085,046,386.0
High: 235.0 Low: 231.35

Open: 234.89 Close: 234.11 Change: -0.78

Read more →
...
April 30, 2023 11:14 (London Time)

Amgen

Amgen stock (NASDAQ: AMGN) has seen a substantial 23% rise this year, far better than the broader S&P500 index, which is down 18%. Amgen announced t…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.91
MarketCap: 128,072,712,192
High: 240.1 Low: 233.17

Open: 236.82 Close: 239.74 Change: 2.92

Read more →
...
March 13, 2024 13:49 (London Time)

Amgen

Amgen reported fourth-quarter 2023 adjusted earnings of $4.71 per share, beating the Zacks Consensus Estimate of $ 4.66 per share. General Dynamics …
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9814
MarketCap: 148,208,372,071.0
High: 278.48 Low: 277.54

Open: 276.85 Close: 277.93 Change: 1.08

Read more →
...
March 08, 2024 5:09 (London Time)

Amgen

Amgen reported fourth-quarter 2023 adjusted earnings of $4.71 per share, beating the Zacks Consensus Estimate of $3.66. Amgen closed the acquisition…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9696
MarketCap: 146,230,831,326.0
High: 276.81 Low: 269.58

Open: 276.3 Close: 272.86 Change: -3.44

Read more →
...
February 22, 2024 0:29 (London Time)

Amgen

Amgen (AMGN) reported Q4 2023 earnings per share (EPS) of $1.42 , missing estimates of $4.59 by 69.06%. Amgen is letting go of 350 employees followi…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9857
MarketCap: 151,997,318,701.0
High: 285.78 Low: 280.83

Open: 284.84 Close: 283.46 Change: -1.38

Read more →
...
February 17, 2024 20:21 (London Time)

Amgen

Amgen Inc. stock outperforms competitors despite losses on the day. Japan and Asia Pacific (JAPAC) is the fastest growing region in Amgen. Wall Stre…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9332
MarketCap: 152,066,988,158.0
High: 287.71 Low: 283.27

Open: 287.71 Close: 283.7 Change: -4.01

Read more →
...
February 16, 2024 18:17 (London Time)

Amgen

Amgen Inc. announced financial results for the fourth quarter and full year 2023 versus comparable periods in 2022. Goldman Sachs continues with the…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9705
MarketCap: 154,918,076,712.0
High: 287.71 Low: 283.34

Open: 287.88 Close: 285.88 Change: -2.01

Read more →
...
February 03, 2024 22:03 (London Time)

Amgen

Over the past month, shares of Amgen have returned +4.5% versus the Zacks S&P 500 composites +1.6% change. Amgen revenue increased by just 4% year o…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9799
MarketCap: 173,049,815,030.0
High: 325.77 Low: 320.75

Open: 323.64 Close: 323.19 Change: -0.45

Read more →
...
February 02, 2024 5:52 (London Time)

Amgen

Amgen (NASDAQ:AMGN) is in the Health Care sector and Biotechnology industry. Q1 earnings are confirmed for Thursday, April 25, 2024. ETC-1002 may no…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9725
MarketCap: 173,756,250,026.0
High: 324.82 Low: 313.7

Open: 314.5 Close: 324.56 Change: 10.06

Read more →
...
January 21, 2024 0:29 (London Time)

Amgen

Amgen Inc. closed at $302.25 on Friday 01/19/2024, this is a gain of 1.81% compared to the opening price on Friday. Amgen has reached a deal with th…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.8225
MarketCap: 164,722,444,930.0
High: 309.09 Low: 301.11

Open: 304.73 Close: 307.81 Change: 3.08

Read more →
...
January 20, 2024 4:18 (London Time)

Amgen

Amgen (NASDAQ:AMGN) Can Stay On Top Of Its Debt? We think amgen (nasdaq:amgn) can stay on top of its debt. Amgen recently bought Horizon Therapeutic…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.8591
MarketCap: 164,722,444,930.0
High: 309.09 Low: 301.11

Open: 304.73 Close: 307.81 Change: 3.08

Read more →
...
January 14, 2024 9:08 (London Time)

Amgen

Amgen is expected to release next earnings on 02/06/2024 with an earnings per share estimate of $4.60. Amgen shares were roughly flat in morning tra…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9718
MarketCap: 164,037,417,055.0
High: 306.95 Low: 303.4

Open: 305.24 Close: 306.51 Change: 1.27

Read more →
...
December 28, 2023 7:03 (London Time)

Amgen

Amgen raises dividend to $2.25 a share for first quarter of 2024. Amgen is 135.32% away from the 52-week low. FDA approves Amgen biosimilar challeng…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9392
MarketCap: 153,344,560,076.0
High: 287.29 Low: 283.35

Open: 284.5 Close: 286.53 Change: 2.03

Read more →
...
December 24, 2023 5:04 (London Time)

Amgen

Amgen announced a $650 million write-down after discontinuing AMG 340, a prostate cancer candidate acquired in the $900 million buy of Tenobio in 20…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9565
MarketCap: 152,076,188,152.0
High: 285.68 Low: 280.0

Open: 280.0 Close: 284.16 Change: 4.16

Read more →
...
December 18, 2023 14:45 (London Time)

Amgen

Amgen Inc. stock outperforms competitors despite losses on the day - marketwatch.com.com.
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9944
MarketCap: 147,414,787,537.0
High: 277.0 Low: 274.54

Open: 276.27 Close: 276.17 Change: -0.1

Read more →
...
December 10, 2023 9:26 (London Time)

Amgen

Amgen (NASDAQ:AMGN) shareholders have earned a 9.8% share. Amgen acquired Horizon Therapeutics last month. Federal Circuit demanded full scope enabl…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9568
MarketCap: 144,027,110,626.0
High: 271.97 Low: 268.82

Open: 271.17 Close: 269.12 Change: -2.05

Read more →
...
December 06, 2023 7:02 (London Time)

Amgen

Amgen Inc. stock underperforms t Tuesday when compared to competitors - marketwatch.com. Amgen acquired Horizon Therapeutics last month.
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9022
MarketCap: 145,815,140,414.0
High: 272.0 Low: 268.47

Open: 271.87 Close: 270.87 Change: -1.0

Read more →
...
December 03, 2023 13:25 (London Time)

Amgen

Amgen stock rose 262% in pre-quarter trade on Tuesday. Company raised full-year revenue guidance. Amgen is cutting 450 members of its workforce.
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9545
MarketCap: 145,830,660,577.0
High: 272.59 Low: 267.62

Open: 269.96 Close: 272.45 Change: 2.49

Read more →
...
November 30, 2023 11:44 (London Time)

Amgen

Amgen is expanding its work with Amazon Web Services to create generative AI in a bid to increase the manufacturing throughput of pharmaceuticals. T…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9893
MarketCap: 142,678,461,998.0
High: 268.11 Low: 263.5

Open: 264.74 Close: 266.6 Change: 1.86

Read more →
...
November 22, 2023 12:53 (London Time)

Amgen

Amgen Inc. (amgn) stock price, quote & news - stock analysis. Amgen stock +0.62% in premarket trade, after the biotech blew past earnings estimates …
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.8883
MarketCap: 140,687,599,737.0
High: 266.04 Low: 260.52

Open: 265.34 Close: 262.82 Change: -2.52

Read more →
...
November 19, 2023 21:27 (London Time)

Amgen

Amgen Inc. recently announced a dividend of $2.13 per share, payable on 2023-12-08, with the ex-dividend date set for 2023. The biopharma company re…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.7964
MarketCap: 142,030,896,585.0
High: 269.41 Low: 264.6

Open: 269.41 Close: 265.39 Change: -4.02

Read more →
...
November 02, 2023 15:01 (London Time)

Amgen

Amgen Inc. will host a webcasted call for the investment community at 8:00 a.m. on November 19. Amgen expects full-year earnings in the range of $18…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.8519
MarketCap: 139,523,624,052.0
High: 266.77 Low: 262.46

Open: 263.3 Close: 265.12 Change: 1.83

Read more →
...
October 29, 2023 8:02 (London Time)

Amgen

Amgen to Lay Off 350 U.S. employees of Horizon Therapeutics. Company has been on somewhat of a cost-cutting spree this year, cutting 300 jobs in Jan…
Sector: Biotechnology
Ticker: AMGN
Sentiment: -0.875
MarketCap: 139,914,101,914.0
High: 269.36 Low: 260.16

Open: 268.95 Close: 261.57 Change: -7.38

Read more →
...
October 12, 2023 9:16 (London Time)

Amgen

Amgen completed its acquisition of Horizon Therapeutics plc for $116.50 per share in cash. FDA panel will not give its blessing to approval of Amgen…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9192
MarketCap: 145,091,945,346.0
High: 284.33 Low: 274.15

Open: 274.86 Close: 283.6 Change: 8.74

Read more →
...
October 06, 2023 14:44 (London Time)

Amgen

Piper Sandler analyst Christopher Raymond maintained a Buy rating on Amgen today and set a price target of $288.00. The word on The Street suggests …
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9882
MarketCap: 141,791,605,059.0
High: 266.26 Low: 262.23

Open: 263.15 Close: 266.09 Change: 2.94

Read more →
...
September 23, 2023 3:19 (London Time)

Amgen

Amgen is best known for it its rheumatoid arthritis drug Enbrel, which contributed 17% of sales last year. Amgen hosted inaugural scientific summit …
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9664
MarketCap: 144,107,727,173.0
High: 269.49 Low: 266.56

Open: 267.67 Close: 267.7 Change: 0.03

Read more →
...
September 20, 2023 20:21 (London Time)

Amgen

Amgen is best known for it its rheumatoid arthritis drug Enbrel, which contributed 17% of sales last year. The FTC announced a settlement of its cha…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9324
MarketCap: 141,379,731,150.0
High: 273.08 Low: 263.97

Open: 265.0 Close: 271.46 Change: 6.46

Read more →
...
September 09, 2023 20:23 (London Time)

Amgen

FTC settles with Amgen over $27.8 billion takeover of Horizon Therapeutics. FTC had filed a lawsuit in May seeking to block the acquisition, arguing…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9705
MarketCap: 138,769,413,386.0
High: 260.34 Low: 254.97

Open: 255.75 Close: 259.43 Change: 3.68

Read more →
...
September 05, 2023 9:48 (London Time)

Amgen

Amgen $27.8 billion deal for horizon therapeutics clears key hurdle - wsj. amgens.com.
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.3182
MarketCap: 137,314,482,174.0
High: 259.03 Low: 256.1

Open: 258.68 Close: 256.71 Change: -1.97

Read more →
...
September 04, 2023 16:53 (London Time)

Amgen

Federal Trade Commission (FTC) has allowed Amgen to continue its $27.8 billion acquisition of Horizon Therapeutics. FTC in May filed a lawsuit over …
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9509
MarketCap: 137,314,482,174.0
High: 259.03 Low: 256.1

Open: 258.68 Close: 256.71 Change: -1.97

Read more →
...
August 17, 2023 11:09 (London Time)

Amgen

Amgen (NASDAQ:AMGN) is now the time to put amgen (nasdaq:amgn) on your watchlist? Amgen is a biotechnology company, which discovers, develops, manuf…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9909
MarketCap: 141,759,510,988.0
High: 268.24 Low: 264.58

Open: 266.33 Close: 265.02 Change: -1.31

Read more →
...
August 12, 2023 18:14 (London Time)

Amgen

Amgen stock (NASDAQ: AMGN) has seen a 17% rise in a month, outperforming the broader S&P500 index, up 1%. Amgen plans to close its $28 billion Horiz…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.986
MarketCap: 140,176,203,492.0
High: 264.11 Low: 260.83

Open: 261.7 Close: 262.51 Change: 0.81

Read more →
...
August 08, 2023 14:44 (London Time)

Amgen

Amgen announces 2023 third quarter dividend for the third quarter of 2023. Amgen announced revenue of $6.99 billion, up 6% from a year earlier, abov…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9936
MarketCap: 135,297,904,722.0
High: 262.77 Low: 256.5

Open: 257.52 Close: 258.83 Change: 1.32

Read more →
...
July 31, 2023 21:20 (London Time)

Amgen

Amgen (NASDAQ:AMGN) stock price for Amgen is $ 234.15 last updated Today at July 31, 2023 at 8:00 PM UTC. Amgen and TSCAN THERAPEUTics have announce…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9929
MarketCap: 126,298,777,023.0
High: 236.48 Low: 233.02

Open: 236.48 Close: 234.15 Change: -2.33

Read more →
...
July 19, 2023 7:01 (London Time)

Amgen

Amgen (AMGN) closed at $227.66, marking a +0.88% move from the previous day. Amgen has its Repatha (evolocumab) PCSK9i inhibitor that lowers LDL-C l…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9929
MarketCap: 124,268,335,966.0
High: 234.07 Low: 227.4

Open: 227.79 Close: 232.57 Change: 4.78

Read more →
...
July 13, 2023 16:15 (London Time)

Amgen

Amgen has outperformed the market over the past 15 years by 1.31% on an annualized basis producing an average annual return of 10.23%. Amgen sells p…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9817
MarketCap: 120,597,512,265.0
High: 227.88 Low: 225.0

Open: 225.85 Close: 227.07 Change: 1.22

Read more →
...
June 27, 2023 22:01 (London Time)

Amgen

Amgen closed at $227.11, marking a -1.11% move from the previous day. Amgen is projected to report earnings of $4.46 per share, which would represen…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.8934
MarketCap: 120,079,215,469.0
High: 224.62 Low: 221.13

Open: 224.16 Close: 222.61 Change: -1.55

Read more →
...
June 22, 2023 18:39 (London Time)

Amgen

Amgen makes money by creating treatments for medical conditions affecting millions. Amgen collected $6.1 billion in revenues, down 2.1% in the first…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9623
MarketCap: 121,313,509,901.0
High: 229.67 Low: 226.76

Open: 227.31 Close: 229.04 Change: 1.73

Read more →
...
June 20, 2023 14:14 (London Time)

Amgen

Amgen (AMGN) closed at $229.66 in the latest trading session, marking a +0.53% move from the previous day. Amgen revenue was $26.32 billion, an incr…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.431
MarketCap: 122,713,445,578.0
High: 230.27 Low: 227.19

Open: 229.03 Close: 228.77 Change: -0.26

Read more →
...
June 07, 2023 4:54 (London Time)

Amgen

Federal Trade Commission expected to introduce lawsuit to block $27.8 billion merger with Amgen. Johnson & Johnson settled lawsuit over Amgens propo…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9207
MarketCap: 118,556,384,676.0
High: 223.17 Low: 219.28

Open: 223.08 Close: 221.22 Change: -1.86

Read more →
...
June 02, 2023 22:47 (London Time)

Amgen

Federal Trade Commission (FTC) signaled it had enough amgen deal to block amgen mega pharma deals after it announced it would try to block it. FTC s…
Sector: Biotechnology
Ticker: AMGN
Sentiment: -0.945
MarketCap: 126,085,046,386.0
High: 218.76 Low: 212.02

Open: 213.75 Close: 218.07 Change: 4.32

Read more →
...
May 26, 2023 1:35 (London Time)

Amgen

FTC said it opposed the deal because of concerns Amgen would leverage its big selling drugs. Elizabeth Warren wrote a blistering letter opposing Amg…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9584
MarketCap: 126,085,046,386.0
High: 220.0 Low: 214.93

Open: 220.1 Close: 217.46 Change: -2.64

Read more →
...
May 23, 2023 18:29 (London Time)

Amgen

Amgen Inc. (AMGN) stock has fallen 4.31% in a week. Federal Trade Commission (FTC) said Tuesday it will sue to stop Amgen $27.8 billion acquisition …
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.6801
MarketCap: 126,085,046,386.0
High: 226.82 Low: 222.8

Open: 224.21 Close: 225.29 Change: 1.08

Read more →
...
May 20, 2023 14:40 (London Time)

Amgen

Federal Trade Commission sues to block Amgen $27.8 billion takeover of Horizon Therapeutics. FTC says deal would give Amgen unfair leverage to block…
Sector: Biotechnology
Ticker: AMGN
Sentiment: -0.9813
MarketCap: 126,085,046,386.0
High: 225.88 Low: 222.78

Open: 224.44 Close: 223.42 Change: -1.02

Read more →
...
May 19, 2023 16:11 (London Time)

Amgen

Federal Trade Commission is seeking to block biopharmaceutical giant Amgen from acquiring Horizon Therapeutics. FTC filed a lawsuit in federal court…
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.8689
MarketCap: 126,085,046,386.0
High: 225.88 Low: 223.56

Open: 224.44 Close: 224.06 Change: -0.38

Read more →
...
May 18, 2023 7:18 (London Time)

Amgen

FTC says deal would enable Amgen to exploit its size to block competition for two expensive Horizon drugs. FTC says it opposed the deal because it w…
Sector: Biotechnology
Ticker: AMGN
Sentiment: -0.8201
MarketCap: 126,085,046,386.0
High: 226.09 Low: 220.44

Open: 226.02 Close: 225.02 Change: -1.0

Read more →
...
May 02, 2023 23:34 (London Time)

Amgen

Amgen (NASDAQ:AMGN) Upcoming Dividend Will be Larger Than Last Years. Amgen looks like a great income stock, and it is only getting better by paying…
Sector: Biotechnology
Ticker: AMGN
Sentiment: -0.9926
MarketCap: 126,085,144,576
High: 239.0 Low: 235.39

Open: 238.08 Close: 235.97 Change: -2.11

Read more →
...
April 29, 2023 23:25 (London Time)

Amgen

Amgen expects full-year earnings in the range of $17.60 to $18.70 per share. Both trials involving two different molecules were stopped for futility.
Sector: Biotechnology
Ticker: AMGN
Sentiment: 0.9875
MarketCap: 128,072,712,192
High: 240.1 Low: 233.17

Open: 236.82 Close: 239.74 Change: 2.92

Read more →